secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2025-10-20T23:59:59+00:00
Accession:  0001493152-25-018583
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech furnishes investor presentation for Maxim Growth Summit 2025
---------------------------------------------------------------------------

- Presentation furnished for Maxim Growth Summit 2025 taking place Oct 22-23, 2025 in New York.
- No material new financial or operational data disclosed; presentation contains forward-looking statements.
- Highlights Ampligen development for viral diseases, cancers, and immune-deficiency disorders.
- Filing states information is furnished, not filed, and not incorporated by reference.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/0001493152-25-018583-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315225018583/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-018583

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer